Tau-targeting therapies for Alzheimer disease: current status and future directions
Erin E. Congdon(Neurosciences Institute), Einar M. Sigurdsson(Neurosciences Institute)
Cited by 309
Related Papers
Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology
|Science Advances|2023|36
Dynamic assessment of tau immunotherapies in the brains of live animals by two-photon imaging
|EBioMedicine|2018|35
Single-domain antibody-based protein degrader for synucleinopathies
|Molecular Neurodegeneration|2024|12
Anti-tau single domain antibodies clear pathological tau and attenuate its toxicity and related functional defects
|Cell Death and Disease|2024|7
Neuronal hypofunction and network dysfunction in a mouse model at an early stage of tauopathy
|Alzheimer s & Dementia|2024|4